JPRN-UMIN000030248
Recruiting
未知
Mapping of brain tau deposition in tauopathy by PET with [18F]PM-PBB3 - Mapping of brain tau deposition in tauopathy by PET with [18F]PM-PBB3
ational Institute of Radiological Sciences0 sites200 target enrollmentJanuary 1, 2018
Conditionsmild cognitive impairment, Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy, frontotemporal degeneration, Parkinson's disease, Lewy body dementia,Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex Patients in Kii Peninsula, Diffuse neurofibrillary tangles with calcification, hereditary diffuse leukoencephalopathy with spheroid,Progressive Ataxia and Palatal Tremor, traumatic brain injury
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- mild cognitive impairment, Alzheimer'
- Sponsor
- ational Institute of Radiological Sciences
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Subjects with neurodegenerative disease 1\. Subjects with organic brain complications/disorders 2\.Subjects with substance\-related disorders 3\.Subjects with severe physical complications/disorders or a history of such conditions 4\. Subjects with claustrophobia 5\. Pregnant, possibly pregnant or lactating women 6\. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 7\. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 2\) Subjects with traumatic brain injury 1\. Subjects with any organic brain disorder not due to traumatic brain injury 2\. Subjects with severe physical complications/disorders or a history of such conditions 3\. Subjects with claustrophobia 4\. Pregnant, possibly pregnant or lactating women 5\. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 6\. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 3\) Healthy volunteers 1\. Subjects with organic brain complications/disorders 2\. Subjects with substance\-related disorders 3\.Subjects with severe physical complications/disorders or a history of such conditions 4\. Subjects with claustrophobia 5\. Pregnant, possibly pregnant or lactating women 6\. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study 7\. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 8\. Subjects with tattoo 9\. Subjects with metallic medical device in the body
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Mapping of brain tau deposition in tauopathy by PET with [11C]PBB3Healthy volunteers 20 years of age or older at the time of obtaining consent Patients with mild cognitive impairment (MCI) 20 years of age or older at the time of obtaining consent Patients with Alzheimer's disease (AD) 20 years of age or older at the time of obtaining consent Patients with corticobasal degeneration (CBD) 20 years of age or older at the time of obtaining consent Patients with progressive supranuclear palsy (PSP) 20 years of age or older at the time of obtaining consent Patients with frontotemporal dementia (FTD) 20 years of age or older at the time of obtaining consent Patients with familial Parkinson's disease with the LRRK2 genetic mutation (PARK8)JPRN-UMIN000009863ational Institute of Radiological Sciences124
Recruiting
Not Applicable
[18F]THK-5351 PET imaging of tau deposits in neurological disorderscorticobasal syndrome, other neurodegenerative disorders, and normal volunteersJPRN-UMIN000021819Tohoku University160
Completed
Not Applicable
PET study of brain tau deposition in late onset psychosis using [11C]PBB3JPRN-UMIN000017837ational Institute of Radiological Sciences57
Active, not recruiting
Phase 1
PET imaging study of the brain tau deposit in individuals with subjective cognitivedecline and mild cognitive impairment: FACEHBI cohort.Subjective cognitive impairment and mild cognitive decline in evaluation fordiagnosis of Alzheimer's Disease.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2021-000473-83-ESFundació ACE-Institut Català de Neurociències Aplicades100
Recruiting
Not Applicable
Detection of tau deposition in normal brain aging and neurodegenerative disorders using tau imaging with [C-11]PBB3 and PETHealthy volunteers and patients with neurodegenerative disordersJPRN-UMIN000014087Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology70